ReviewThe review of diabetic studies : RDS2012

Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

F Susan Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.